Dendritic Cells: A Double-Edge Sword in Atherosclerotic Inflammation

Author(s): Dimitry A. Chistiakov, Igor A. Sobenin, Alexander N. Orekhov, Yuri V. Bobryshev

Journal Name: Current Pharmaceutical Design

Volume 21 , Issue 9 , 2015

Become EABM
Become Reviewer

Abstract:

Functional heterogeneity of dendritic cells (DCs) observed in atherosclerosis suggest for their complex and multifaced role in the pathogenesis of atherosclerotic disease. A delicate balance between anti-inflammatory and pro-inflammatory mechanisms drives atherogenesis, and local microenvironment triggers the actual involvement of DCs in atherosclerosis-associated inflammation. Responding to microenvironment stimuli, DCs contribute to atherogenesis in both ways being involved in supporting proatherogenic vascular inflammation and by suppressing inflammatory responses via induction of self-tolerogenic properties and regulatory T cells (Tregs). The local microenvironment and extrinsic stimuli influence DC phenotype and hence could control the phenotypic switch toward inflammation or tolerance.

Keywords: Atherosclerosis, arteriosclerosis, arteries, inflammation, dendritic cells, plasmacytoid dendritic cells.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 21
ISSUE: 9
Year: 2015
Page: [1118 - 1123]
Pages: 6
DOI: 10.2174/1381612820666141013162528
Price: $65

Article Metrics

PDF: 36
HTML: 2